Add To Watchlist
Share URL
About The Company
Description
Doxa AB (publ), a dental company, develops, manufactures, and commercializes bioceramic dental products under the Ceramir brand worldwide.
Read More
Overview
Value
33
Growth
26
Health
62
Management
36
Analyst Opinion
63
Total
44
All Scores Out Of 100
Best Features
- Earnings growth has improved recently
- Has a low level of debt
- Low risk of bankruptcy
- Has strong financial health
- Price-to-earnings ratio of 9.6 is lower than the market average (19.6x)
- Low preportion of income is paid as dividend
Risk Factors
- Income is not covering expenditure and investment
- Earnings are negative
- There is a history of diluting shareholders
- No margin of safety at their current market price
- Poor earnings and cashflow growth 0
Market Peers
DOXA.ST
Key Figures
PE Ratio (TTM)
9.58
Margin Of Safety (DCF)
-8.05%
Revenue Growth (5 Year Average)
-5.20%
Ratings Consensus
Neutral
Share Buybacks
-6.98%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
33
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 5.8 SEK ✘
Current Price: 5.9 SEK
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
9.58x
Free Cashflow Yeild
-5.96%
PE/Earnings Growth
N/A
Price/Book
0.93x
Growth
Growth Score
26
- ✔ Earnings growth has improved this year
- ✔ 5 Year Average Cashflow growth of 14.67% is higher than the market average (12.35%)
- ✘ 5 Year Average Revenue growth of -5.20% is lower than the market average (10.97%)
- ✘ Revenue growth has slowed this year
- ✘ 5 Year Average Earnings growth of -2.48% is lower than the market average (14.48%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
-5.20%
Earnings Growth
-2.48%
Cashflow Growth
14.67%
Health
Health Score
62
Altman Z Score
20.00
Piostroski Score
3.00
Debt/Equity
0.00x
Current Assets/Liabilities
33.42x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
0.01x
Management
Management Score
36
Average Buybacks/Dilution
-6.98%
Recent Buybacks/Dilution
0.58%
5 Year Price Volitility
85.85%
Return On Assets
-0.47%
Return On Capital Employed
-0.43%
Return On Equity
-0.47%
Return On Free Cashflow
15.00%
Return On Investments
-0.62%
Analysts
Analyst Opinion
63
- ✔ Ratings consensus is Neutral
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Doxa AB (publ)
Currency
SEK
Beta
0.928627
Vol Avg
163352
Ceo
Mr. Victor Persson
Cik
Cusip
Exchange
Stockholm Stock Exchange
Full Time Employees
10
Industry
Medical Instruments & Supplies
Sector
Healthcare
Ipo Date
2014-04-07
Address
Axel Johanssons gata 4-6
City
Uppsala
State
Country
SE
Zip
754 50
Phone
46 1 84 78 20 00
All financial data provided by FMP